CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND RETAINED EARNINGS (UNAUDITED) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
COMPREHENSIVE INCOME
Net Earnings	$ 1,307	$ 1,268	$ 2,674	$ 2,369
Other Comprehensive Income/(Loss):
Foreign currency translation	16	(6)	28	(40)
Foreign currency translation on net investment hedges	(5)	64	(57)	143
Derivatives qualifying as cash flow hedges, net of taxes of $15 and $(17) for the three months ended June 30, 2011 and 2010, respectively; and $26 and $(30) for the six months ended June 30, 2011 and 2010, respectively	(31)	40	(57)	69
Derivatives qualifying as cash flow hedges reclassified to net earnings, net of taxes of $(6) and $2 for the three months ended June 30, 2011 and 2010, respectively; and $(7) and $(3) for the six months ended June 30, 2011 and 2010, respectively	12	(4)	13	6
Pension and postretirement benefits, net of taxes of $4 for both the three and six months ended June 30, 2010		(12)		(12)
Pension and postretirement benefits reclassified to net earnings, net of taxes of $(11) for both the three months ended June 30, 2011 and 2010, respectively; and $(19) and $(23) for the six months ended June 30, 2011 and 2010, respectively	18	26	37	43
Available for sale securities, net of taxes of $(8) and $(2) for the three months ended June 30, 2011 and 2010, respectively; and $(3) and $(1) for the six months ended June 30, 2011 and 2010	15	17	18	32
Total Other Comprehensive Income/(Loss)	25	125	(18)	241
Comprehensive Income	1,332	1,393	2,656	2,610
Comprehensive Income Attributable to Noncontrolling Interest	405	341	786	699
Comprehensive Income Attributable to Bristol-Myers Squibb Company	927	1,052	1,870	1,911
RETAINED EARNINGS
Retained Earnings at January 1			31,636	30,760
Net Earnings Attributable to Bristol-Myers Squibb Company	902	927	1,888	1,670
Cash dividends declared			(1,132)	(1,108)
Retained Earnings at June 30	$ 32,392	$ 31,322	$ 32,392	$ 31,322